SEBACEOUS CARCINOMA: A RARE CASE REPORT AND DIAGNOSTIC APPROACH
Main Article Content
Abstract
Sebaceous carcinoma is a rare malignant tumor, commonly found in the periocular and head and neck regions, easily misdiagnosed with chronic inflammatory diseases or benign tumors. Early diagnosis plays an important role in improving prognosis and choosing the optimal treatment strategy. Objective: To describe the clinical presentation and diagnostic approach of sebaceous carcinoma. Results: A 73-year-old female patient with a history of stable type 2 diabetes mellitus presented with a skin lesion on the right cheek for more than 1 year, a yellowish nodule, slowly progressing, occasionally ulcerating and forming a yellow crust. Examination revealed a round papule:1 cm, clear boundary, segmented surface, ulceration and black pigment spots, slight infiltration. Biopsy and immunohistochemistry (EMA (+), Ber-EP4 (-), Bcl-2 (+)) suggested sebaceous carcinoma. The patient underwent wide excision with reconstruction, favorable postoperative course, no recurrence after 6 months of follow-up. Conclusion: Sebaceous carcinoma is a rare malignant tumor, with high potential for invasion and metastasis, often overlooked or misdiagnosed due to nonspecific clinical manifestations. Symptoms of pale-yellow facial skin lesions, slow progression, or recurrent ulcers in the elderly. Early biopsy combined with a full immunohistochemical panel for early diagnosis and radical surgery are key factors.
Article Details
Keywords
: sebaceous carcinoma, sebaceous carcinoma, early diagnosis, skin biopsy, case report
References
2. Ansai S ichi, Takeichi H, Arase S, Kawana S, Kimura T. Sebaceous Carcinoma: An Immunohistochemical Reappraisal. The American Journal of Dermatopathology. 2011;33(6):579-587. doi:10.1097/DAD.0b013e31820a2027
3. Helmi HA, Alsarhani W, Alkatan HM, Al-Rikabi AC, Al-Faky YH. Sebaceous Gland Carcinoma with Misleading Clinical Appearance: A Case Report of an Eyelid Lesion. Am J Case Rep. 2020;21:e925134. doi:10.12659/AJCR.925134
4. Mulay K, White VA, Shah SJ, Honavar SG. Sebaceous carcinoma: clinicopathologic features and diagnostic role of immunohistochemistry (including androgen receptor). Canadian Journal of Ophthalmology. 2014;49(4):326-332. doi:10.1016/j.jcjo.2014.04.004
5. Fan YS, Carr RA, Sanders DSA, Smith AP, Lazar AJF, Calonje E. Characteristic Ber‐EP4 and EMA expression in sebaceoma is immunohistochemically distinct from basal cell carcinoma. Histopathology. 2007;51(1):80-86. doi:10.1111/j.1365-2559.2007.02722.x
6. Mittal R, Araujo I, Czanner G, Coupland SE. Perforin expression in eyelid sebaceous carcinomas: a useful and specific immunomarker for the differential diagnosis of eyelid carcinomas. Acta Ophthalmologica. 2016;94(5). doi:10.1111/ aos.12972
7. Niinimäki P, Siuko M, Tynninen O, Kivelä TT, Uusitalo M. Sebaceous carcinoma of the eyelid: 21‐year experience in a Nordic country. Acta Ophthalmologica. 2021;99(2): 181-186. doi:10. 1111/aos.14552